A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Sarkana Pharma Inc
- Target Recruit Count
- 16
- Registration Number
- NCT05156034
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
© Copyright 2025. All Rights Reserved by MedPath